Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Research & Drug Development

2004

E. Perucca; M. Onofrj; A. Thomas; C. Cattaneo; RG Fariello
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (Eilat VII)
Epilepsy Res. 2004 Sep-Oct; 61 (1-3): 12-14

Cibele Sabido-David, L. Faravelli, P. Salvati
The therapeutic potential of sodium and calcium channel blockers in pain management
Expert Opin Investig Drugs 2004 Oct.: 13(10) 1249-61

O. Veneroni, E. Izzo, G. Graziani, S. Parini, L. Dho, P. Salvati
Antiallodynic effect of ralfinamide in spinal nerve ligation rat model of neuropathic pain
XXXth Annual Meeting Society for Neuroscience, San Diego, CA (USA), October 23-27, 2004

E. Izzo,O. Veneroni, G. Graziani, P. Paudice, M. Raiteri, P. Salvati
Anti-inflammatory effect of ralfinamide on carraggeenan-induced paw oedema in rat and on spinal cord synaptosomes substance P release
XXXth Annual Meeting Society for Neuroscience, San Diego, CA (USA), October 23-27, 2004

C. Besana; S. Rossetti; C. Cattaneo
Significant improvement of motor function in early Parkinson Disease (PD) with safinamide
13th International Conference on Pharmaceutical Medicine Ginevra 19/22 September - 2004

L. Leonetti; P. Salvati; C. Caccia; A. Carotti
Sintesi su fase solida della safinamide e suoi analoghi
XVII Convegno Nazionale della Divisione di Chimica Farmaceutica della Società
Chmica Italiana Pisa, 6-10 Settembre - 2004

F. Stocchi; G. Arnold; M. Onofrj; H. Kwiecinski; A Szczudlik; A. Thomas; U. Bonuccelli; A. Van Dijk; C. Cattaneo; P. Sala; R. Fariello
Improvement of motor function in early Parkinson Disease by Safinamide
Neurology August 2004; 63

A. Restivo; S. Francisconi; T. Stummann; L Faravelli; C. Sabido David; C. Caccia
Functional fluorescent cell based assays for screening ion channel targets
4th Forum of European Neuroscience Lisbon, Portugal, 10-14 July - 2004 FENS Abstr.; Vol.2 , A012.18 - 2004

A. Marzo; L. Dal Bo; N. Ceppi Monti; F. Crivelli; S. Ismaili; C. Caccia; C. Cattaneo; R. Fariello
Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity
Pharmalogical Research, Volume 50, Issue 1, July 2004, Pages 77-85